// App-Quantinova.ai

: PBI-4050 Improves Metabolic Regulation and Diabetic Nephropathy through Reduction of ER Stress, Pro-Inflammatory/Fibrotic Markers, Galectin-3 Expression, and Inflammatory Cell Infiltration in ob/ob Mouse Model

Researchers

Presenter

  • JEAN-CHRISTOPHE SIMARD

Principal Investigators

  • MARIE-PIER CLOUTIER

  • ALEXANDRE LAVERDURE

  • JONATHAN RICHARD

  • LIETTE GERVAIS

  • ALEXANDRA FELTON

  • BRIGITTE GROUIX

  • PIERRE LAURIN

  • MARTIN LEDUC

  • FRANcOIS A. LEBLOND

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Galectin-3

Drug/Treatment

  • PBI4050

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved